Azathioprine and methotrexate are “traditional” immunosuppressive agents commonly used, though their clinical effect can take months to appear, and anti-TNF (tumor necrosis factor) monoclonal antibodies are increasingly being introduced early in the immunosuppressive treatment of neurosarcoidosis [20]. This evidence concerns the gene TNF and neurosarcoidosis.